Healthcare Costs Are Rising Faster Than Inflation — and Driving Up Health Insurance Costs
Blue Daily
| 2 min read
Key Takeaways
- Hospital and prescription drug costs rose nearly three times faster than inflation, driving higher healthcare expenses nationwide.
- Hospital care represented 31% of U.S. healthcare spending and received the largest share of premium dollars.
- Rising healthcare costs increase financial pressure on families and employers through premiums, deductibles, copayments and benefits decisions.
- Blue Cross is lowering costs through administrative savings, biosimilars and value-based care that reduces unnecessary spending.
In 2024, hospital spending rose 8.9%. Prescription drug spending rose 7.9% while inflation was 2.9%. That means two of the biggest healthcare expenses grew nearly three times faster than the prices of everyday goods and services. Hospital care alone accounted for 31% of U.S. health spending in 2024 — $1.6 trillion.
These increases are reflected in health insurance costs, because insurers pay hospitals, doctors and pharmacies for members’ care. At Blue Cross Blue Shield of Michigan, hospitals received 46% of every premium dollar collected in 2025 — the largest single share of the health insurance dollar.
What this means for people and employers
For families, higher health insurance costs can mean more money taken from each paycheck, larger deductibles and higher copayments when care is needed.
For employers, rising premiums can force difficult decisions about benefits, wages, hiring and investment. Some small businesses may be unable to continue offering coverage.
Healthcare cannot remain affordable if its biggest costs continue to rise far faster than inflation. The answer must include lower prices, better care, less waste and stronger accountability from providers, drug companies and insurers.
What Blue Cross Blue Shield of Michigan is doing
Blue Cross Blue Shield of Michigan is committed to solutions to make healthcare affordable. In 2025, we reduced administrative costs by $420 million and are working toward a $600 million reduction by 2027.
Prescription drug cost growth also dramatically slowed across commercial health plans from 15% in 2024 to 2.6% in 2025. The use of lower-cost biosimilars prescriptions saved members and employers $80 million, while drug discount programs saved members more than $100 million in out-of-pocket costs.
Through value-based care, Blue Cross is also changing how providers are paid — rewarding quality, prevention and better outcomes instead of simply paying for more services. These programs have helped avoid $6.3 billion in unnecessary medical expenses that otherwise could have flowed into premiums.
Learn more about how Blue Cross is working to make healthcare more affordable at mibluedaily.com/affordability.
Photo credit: Getty Images
